Low levels of insulin-like growth factor-1 contribute to alveolar macrophage dysfunction in cystic fibrosis.
Low levels of insulin-like growth factor-1 contribute to alveolar macrophage dysfunction in cystic fibrosis.
复制标题
DOI:
10.4049/jimmunol.1300221
复制
发表时间:
2013-07-01
期刊:
影响因子:
--
通讯作者:
Ashare A
中科院分区:
文献类型:
--
作者:
Bessich JL;Nymon AB;Moulton LA;Dorman D;Ashare A
Alveolar macrophages are major contributors to lung innate immunity. Although alveolar macrophages from CFTR−/− mice have impaired function, no study has investigated primary alveolar macrophages in adults with cystic fibrosis (CF). CF patients have low levels of insulin-like growth factor 1 (IGF-1), and our prior studies demonstrate a relationship between IGF-1 and macrophage function. We hypothesize that reduced IGF-1 in CF leads to impaired alveolar macrophage function and chronic infections. Serum and bronchoalveolar lavage (BAL) samples were obtained from 8 CF subjects and 8 healthy subjects. Macrophages were isolated from BAL fluid. We measured the ability of alveolar macrophages to kill Pseudomonas aeruginosa. Subsequently, macrophages were incubated with IGF-1 prior to inoculation with bacteria to determine the effect of IGF-1 on bacterial killing. We found a significant decrease in bacterial killing by CF alveolar macrophages compared to controls. CF subjects had lower serum and BAL IGF-1 levels compared to healthy controls. Exposure to IGF-1 enhanced alveolar macrophage macrophages in both groups. Finally, exposing healthy alveolar macrophages to CF BAL fluid decreased bacterial killing, and this was reversed by the addition of IGF-1, while IGF-1 blockade worsened bacterial killing. Our studies demonstrate that alveolar macrophage function is impaired in patients with CF. Reductions in IGF-1 levels in CF contribute to the impaired alveolar macrophage function. Exposure to IGF-1 ex vivo, results in improved function of CF alveolar macrophages. Further studies are needed to determine whether alveolar macrophage function can be enhanced in vivo with IGF-1 treatment.
登录
查看更多内容
影响因子:
5.4
作者:
Page, Carly;Goicochea, Lindsay;Frieman, Matthew
通讯作者:
Frieman, Matthew
DOI:
10.1016/j.bbrc.2010.03.072
发表时间:
2010-04-09
影响因子:
3.1
作者:
Furundzija, Vesna;Fritzsche, Jan;Stawowy, Philipp
通讯作者:
Stawowy, Philipp
影响因子:
5.2
作者:
Murphy, Brian S.;Bush, Heather M.;Feola, David J.
通讯作者:
Feola, David J.
影响因子:
3.3
作者:
Barriere, Herve;Bagdany, Miklos;Lukacs, Gergely L.
通讯作者:
Lukacs, Gergely L.
DOI:
10.1152/ajpgi.00550.2005
发表时间:
2006-07-01
影响因子:
4.5
作者:
Ahmed, Tamer;Yumet, Gladys;Cooney, Robert N.
通讯作者:
Cooney, Robert N.